FDL169
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Flatley Discovery Lab LLC
Overview
FDL169 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
FDL169 clinical trials
Explore related
Medical disclaimer. This page summarizes research about FDL169 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.